Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

carbohydrate/obesità

Il collegamento viene salvato negli appunti
Pagina 1 a partire dal 48 risultati

Nutrition for obese patients

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND This invention relates generally to compositions and methods for the treatment and nutritional support of patients. More specifically, this invention relates to the nutritional support of obese patients prior to, during and after hospitalisation for surgery, treatment of diseases or other

Fat removal device and obesity treatment

Solo gli utenti registrati possono tradurre articoli
Entra registrati
RELATED APPLICATION This application is a non-provisional patent application of provisional patent application Ser. No. 61/473,779 filed Apr. 10, 2011. FIELD AND BACKGROUND OF THE INVENTION The present invention, in some embodiments thereof, relates to obesity treatment and, more particularly, but

Composition for treatment of obesity

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND 1. Field of the Invention The present invention relates to the field of treatment of gastrointestinal disorders, hyperlipidemia, autoimmune diseases and obesity. More particularly, the present invention relates to a probiotic composition, and a method for treatment of obesity using the

Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION I. Field of the Invention The present invention relates to diets for humans. More particularly, the present invention relates to a dietary system for the treatment of obesity and for the lowering of saturated fats in the blood. The system includes a diet that restricts

Edible foam product for the treatment or prevention of obesity

Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD OF THE INVENTION The present invention relates to an edible foam product with high in-mouth and gastric stability and to its use in the treatment or prevention of obesity. The invention also concerns a pressurised container holding an edible liquid composition and a propellant, which

Carbohydrate absorption inhibitor and method for manufacturing the same

Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION This invention relates to carbohydrate absorption inhibitor and method for manufacturing the same effective against e.g. diabetes prevention, diet, and so forth. BACKGROUND OF THE INVENTION Polysaccharide (starch, glycogen or the like) contained in food is hydrolyzed by

Carbohydrate fraction and use thereof for a flat postprandial glucose response

Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption. BACKGROUND OF THE INVENTION Glucose is an important source of energy to the cells in the human body and abundantly present in food ingredients. After
SUMMARY In order to reduce the glycemic load in the daily nutrition of diabetics, obese and weight-reducing diets, this invention claims cooking or baking processes and procedures for conventional food, rich in carbohydrates, in which, the structure of the original complex carbohydrates (amyloses,

Composition and method for weight reduction and long term management of obesity

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the field of weight reduction and maintenance of body weight. More specifically, the present invention provides a composition that is particularly suited for the long term management of weight in general, and

Pharmaceutical combinations for treating obesity and food craving

Solo gli utenti registrati possono tradurre articoli
Entra registrati
RELATED APPLICATIONS None. BACKGROUND OF THE INVENTION Numerous studies have documented that medications which increase brain 5-HT, such as fenfluramine, are effective anorectic agents which help obese patients lose weight and which also decrease craving for sweets and carbohydrates (6,23). Evidence

Low glycemic impact breads for the nutrition of diabetics, obese and metabolic syndrome diets

Solo gli utenti registrati possono tradurre articoli
Entra registrati
SUMMARY In order to reduce the glycemic load in the daily nutrition of diabetics, obese and for Metabolic Syndrome diets, this invention claims successive and interdependent: grain selection, milling, kneading, leavening, baking and storing processes and procedures for producing and preserving raw

L- and DL- Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to novel use of the compounds of formula (1) in treating mammalian subjects, including humans, suffering from diseases or conditions which are characterized by reduced blood flow, oxygen availability or carbohydrate

L- and DL-Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to novel use of the compounds of formula (I) in treating mammalian subjects, including humans, suffering from diseases or conditions which are characterized by reduced blood flow, oxygen availability or carbohydrate
BACKGROUND OF THE INVENTION Miglitol (Glyset) is an oral alpha glucosidase inhibitor. Miglitol acts by a reversible inhibitor of membrane-bound intestinal .alpha.-glucoside hydrolase enzymes. Membrane intestinal .alpha.-glucosidases hydrolyze oligosaccharides and disaccharides to glucose and other

Method and formulations for the treatment of obesity

Solo gli utenti registrati possono tradurre articoli
Entra registrati
This invention relates to methods and formulations for the treatment of obesity. BACKGROUND OF THE INVENTION When it is required to bring about weight reduction in over-weight patients, it is naturally necessary to reduce their food intake, since the object of the weight-reduction treatment is to
Unisciti alla nostra
pagina facebook

Il database di erbe medicinali più completo supportato dalla scienza

  • Funziona in 55 lingue
  • Cure a base di erbe sostenute dalla scienza
  • Riconoscimento delle erbe per immagine
  • Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
  • Leggi le pubblicazioni scientifiche relative alla tua ricerca
  • Cerca le erbe medicinali in base ai loro effetti
  • Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti

Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate

Google Play badgeApp Store badge